Julio
Moratinos Areces
Researcher to 2010
Publications by the researcher in collaboration with Julio Moratinos Areces (28)
2011
-
Differential sensitivity to adrenergic stimulation underlies the sexual dimorphism in the development of diabetes caused by Irs-2 deficiency
Biochemical Pharmacology, Vol. 81, Núm. 2, pp. 279-288
2008
-
Adipocytokines: Implications in the prognosis and drug treatment of cardiovascular diseases
Revista Clinica Espanola, Vol. 208, Núm. 5, pp. 239-246
-
Fármacos antidiabéticos. Insulinas y antidiabéticos orales
Velázquez. Farmacología Básica y Clínica (Editorial Médica Panamericana), pp. 621-643
2007
-
Disregulation in sympathetic activity explains gender differences in irs-2knockout mice
Fundamental & Clinical Pharmacology
-
Oral insulin-mimetic compounds that act independently of insulin
Diabetes, Vol. 56, Núm. 2, pp. 486-493
2006
-
The imidazoline I2-site ligands BU 224 and 2-BFI inhibit MAO-A and MAO-B activities, hydrogen peroxide production, and lipolysis in rodent and human adipocytes
European Journal of Pharmacology, Vol. 552, Núm. 1-3, pp. 20-30
2005
-
Methylamine but not mafenide mimics insulin-like activity of the semicarbazide-sensitive amine oxidase-substrate benzylamine on glucose tolerance and on human adipocyte metabolism
Pharmacological Research, Vol. 52, Núm. 6, pp. 475-484
2004
-
Benzylamine exhibits insulin-like effects on glucose disposal, glucose transport and fat cell lipolysis in rabbits and diabetic mice
Fundamental & Clinical Pharmacology
-
Benzylamine exhibits insulin-like effects on glucose disposal, glucose transport, and fat cell lipolysis in rabbits and diabetic mice
Journal of Pharmacology and Experimental Therapeutics, Vol. 309, Núm. 3, pp. 1020-1028
-
Defects in insulin secretion and lipolysis display gender-differences inthe IRS-2 knockout model
Fundamental & Clinical Pharmacology
-
Fármacos antidiabéticos. Insulinas y antidiabéticos orales
Velázquez. Farmacología Básica y Clínica (Editorial Médica Panamericana S.A.), pp. 621-643
2003
-
Ras-GRF1 signaling is required for normal β-cell development and glucose homeostasis
EMBO Journal, Vol. 22, Núm. 12, pp. 3039-3049
2002
-
Role of μ-opioid receptors in insulin release in the presence of inhibitory and excitatory secretagogues
European Journal of Pharmacology, Vol. 448, Núm. 1, pp. 95-104
2001
-
Effects of verapamil and elgodipine on isoprenaline-induced metabolic responses in rabbits
European Journal of Pharmacology, Vol. 415, Núm. 1, pp. 105-115
-
Ligands for I2-imidazoline receptors induce insulin secretion in the rabbit
Fundamental & Clinical Pharmacology
-
Role of opioid receptors on the insulin inhibitory effect induced by a2-adrenoceptor stimulation
Fundamental & Clinical Pharmacology
1999
-
Role of niflumic acid on insulin secretion incuded by excitatory and inhibitory agonists in mouse pancreatic islets
Diabetologia: Clinical, Translational and Experimental Diabetes and Metabolism
1998
-
Role of α2-adrenoceptors on the hyperglycaemic and insulin secretory effects derived from α1- and β-adrenoceptor stimulation in the rabbit
Journal of Autonomic Pharmacology, Vol. 18, Núm. 5, pp. 287-295
1997
-
Comparative effects of calcium channel blockers and indomethacin on insulin secretion and blood pressure increase derived from α1-adrenoceptor stimulation in the rabbit
Journal of Autonomic Pharmacology, Vol. 17, Núm. 5, pp. 293-302
1993
-
Coexistence of β2‐ and β3‐adrenoceptors in plasma potassium control in conscious rabbits
Journal of Autonomic Pharmacology, Vol. 13, Núm. 3, pp. 227-236